Latticework Capital Management Forms Site Management Organization Holding Company, Acquires Catalina Research Institute, LLC


Investment in the platform will bring scalability to managing complex clinical trials

DALLAS, September 13, 2022–(BUSINESS WIRE)–Latticework Capital Management (“LCM”), a Dallas-based private equity firm focused exclusively on investments in healthcare control in the lower middle market, today announced the formation of American Clinical Research Services Holdings (“ACRS”) and its acquisition of Catalina Research Institute, LLC (“CRI” or the “Company”), based in Montclair, California. Financial terms of the transaction were not disclosed.

CRI is a leading independent clinical trials center whose mission is to improve the quality of life of millions of Americans through scientific research. The CRI focuses on trials of high complexity concerning non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, diabetes and other metabolic diseases as well as the central nervous system. Throughout its 15-year history, the company, founded by Joe and Victoria Calleros, has built a strong community model that serves underrepresented populations. ACRS’ acquisition of CRI is the first of what is expected to be multiple investments in the broader Site Management Organization (“SMO”) platform.

Given the challenges of recruiting patients and the increased complexity of clinical trials, CAHR aims to increase efficiency in a highly fragmented industry. The partnership with LCM and ACRS will allow CRI to expand and enhance its value proposition as a full-service provider for Phase I testing needs through drug commercialization.

“CRI has mastered the management of complex clinical trials and we are confident in our ability to build a scalable network of owned and operated sites collectively benefiting from the sharing of best practices, standard operating procedures, budgeting and procurement processes. markets,” said Kyle Bradford, Managing Partner and co-founder of LCM. “With record amounts of capital being raised by pharmaceutical and biotech companies, CRI’s growth, supported by ACRS, will be a blueprint for the future of SMOs working to expand their clinical trial pipelines and grow their revenues. “

LCM has completed over 75 transactions across a wide range of healthcare sub-sectors. The firm uses a ‘top-down’ approach to investing, identifying industry themes and trends and focusing on areas of growth and opportunity.

“Partnering with LCM provides the opportunity to expand our reach while remaining focused on the collective mission of solving the medical issues that matter most to our community,” said Joe Calleros, Founder and CEO of CRI. “The LCM team has clearly demonstrated their understanding of the clinical trial industry as well as how to achieve above-average market revenue growth.”

“There are a number of key trends that will shape the on-site services market in the coming years, including increasing R&D spending, increasing complexity of trials, growing role of dedicated sites and the impact of COVID -19 and decentralized clinical trials,” said Brett Lacher, vice president of LCM. “Commercial clinical trial site services are an attractive and growing market with a strong value proposition for sponsors and a clear rationale for consolidation strategies, and we are delighted to have partnered with CRI to bring implement our collective vision.

LCM Managing Partner Kyle Bradford, Managing Partner Steve Neumann, Vice President Brett Lacher and Partner Nina Saboorian worked on the transaction.

McGuireWoods LLP represented Latticework in the transaction.

About American Clinical Research Services Holdings

American Clinical Research Services Holdings is a clinical trial site management organization focused on complex clinical trials and patient diversity and was created through the acquisition of Catalina Research Institute. ACRS was founded to improve the quality of life of millions of Americans through scientific research. ACRS actively seeks acquisition opportunities to help expand into new geographies and expand its customer base. Please contact to connect further regarding a potential partnership.

For more information, visit

About Latticework Capital Management

Founded in 2015, Latticework Capital Management is a Dallas-based, growth-oriented private equity group focused on control investments in lower-middle-market healthcare companies across the United States. LCM has completed over 75 transactions across a wide range of healthcare sub-sectors and currently has over $335 million in assets under management. LCM leverages its combined 100 years of healthcare and investment experience, as well as its network of industry leaders, to help companies grow and realize their full long-term value. .

More information can be found at

See the source version on


Dan Abrahamson
Back Bay Communications


Comments are closed.